IRWD

$3.50+1.16%visit website

IRONWOOD PHARMACEUTICALS INC

Market Cap

$578M

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.25

60mo monthly vs SPY

P/E (TTM)

4.4

TTM to Jun 2026 · diluted EPS

P/S (TTM)

1.5

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	122,060	47,709	106,506	113,041	389,316
Research & development	22,468	21,863	21,940	22,421	88,692
Selling, general & administrative	21,908	19,293	12,033	11,313	64,547
Operating income	75,484	6,805	72,573	79,307	234,169
Interest expense	8,434	7,886	9,141	7,203	32,664
Pretax income	68,020	455	65,172	73,731	207,378
Income tax	27,940	2,731	24,399	22,440	77,510
Net income	40,080	(2,276)	40,773	51,291	129,868
EPS (basic) ($)	0.25	(0.01)	0.25	0.31	0.80
EPS (diluted) ($)	0.23	(0.01)	0.24	0.31	0.79
Weighted avg. shares (basic)	162,215		163,451	164,405
Weighted avg. shares (diluted)	177,764		166,690	167,179

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 6, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 62 more quarters, back to Mar 2010, with Tormere Pro.

Corporate Events (8-K)

13 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 16, 2026 accepted 7:30 AM ET	5.02Officer / director change	Document SEC ↗
Aug 6, 2026 accepted 7:12 AM ET	2.02Earnings release	Document SEC ↗
Jun 18, 2026 accepted 4:14 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
Jun 15, 2026 accepted 4:05 PM ET	8.01Other events	Document SEC ↗
May 21, 2026 accepted 4:05 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗
May 13, 2026 accepted 8:00 AM ET	5.02Officer / director change	Document SEC ↗
May 7, 2026 accepted 7:10 AM ET	2.02Earnings release	Document SEC ↗
Mar 11, 2026 accepted 7:05 AM ET	8.01Other events	Document SEC ↗
Feb 25, 2026 accepted 7:11 AM ET	2.02Earnings release	Document SEC ↗
Jan 2, 2026 accepted 7:05 AM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

31%

W/W -1.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-07-07	2026-07-09	Silver Ronald	PFO & PAO	Sale	127.9K	$4.52	$578K	313.7K	View
2026-06-16	2026-06-17	McHugh Julie	Director	Sale	21.6K	$3.73	$80K	250.7K	View
2026-03-17	2026-03-17	DENNER ALEXANDER J	Director	Sale	6.73M	$3.05	$20.53M	9.19M	View
2026-02-24	2026-02-25	Gaskins Tammi L	Chief Commercial Officer	Sale	11.2K	$3.66	$41K	213.7K	View
2026-02-24	2026-02-25	Martini Gregory S.	Chief Financial Officer	Sale	11.5K	$3.66	$42K	160.6K	View

1–5 of 15

1 / 3

Recent News

IRWD Dec 2026 5.000 call (IRWD261218C00005000) stock historical prices and data

Yahoo Finance Singapore · 2026-11-04

IRWD Dec 2026 5.000 call (IRWD261218C00005000) stock price, news, quote and history

Yahoo Finance UK · 2026-11-02

IRWD261218C00005000 Interactive Stock Chart | IRWD Dec 2026 5.000 call Stock

Yahoo Finance · 2026-11-02

IRWD Dec 2026 5.000 call (IRWD261218C00005000) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-02

Ironwood Pharmaceuticals to Host Third Quarter 2026 Investor Update Call

Yahoo · 2026-10-28

Ironwood Pharmaceuticals, Inc. Estimates – NASDAQ:IRWD

TradingView · 2026-10-24

Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer

Yahoo · 2026-10-16

Ironwood Pharmaceuticals Appoints Tammi Gaskins CEO, Effective Jan. 1, 2027

Benzinga · 2026-10-16

Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?

Yahoo · 2026-10-07

Ironwood Pharmaceuticals: The Stock Is A Call On The Second Apraglutide Trial - Buy

SeekingAlpha · 2026-10-07

Ironwood Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript

Benzinga · 2026-10-05

PGEN vs. IRWD: Which Biotech Stock Offers Better Growth Potential?

Zacks Investment Research · 2026-09-30

Ironwood Pharmaceuticals to Participate in the Wells Fargo 21st Annual Healthcare Conference

Yahoo Finance · 2026-09-03

Ironwood Pharmaceuticals (NASDAQ:IRWD) Highlights Minervini Trend Template and High Growth Momentum

ChartMill · 2026-08-26

Ironwood (IRWD) Q2 2026 Earnings Call Transcript

Yahoo Finance · 2026-08-13

Informational purposes only, not investment advice.

IRWD

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

IRONWOOD PHARMACEUTICALS INC (IRWD)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-07-07	Silver Ronald	S	127,890	$578,062.8
2026-06-16	McHugh Julie	S	21,571	$80,459.83
2026-03-17	DENNER ALEXANDER J	S	6,725,000	$21M
2026-03-17	DENNER ALEXANDER J	S	5,800	$19,198
2026-02-24	Gaskins Tammi L	S	11,239	$41,134.74